Patents by Inventor Carlton Morgan

Carlton Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060200206
    Abstract: The following disclosure describes several methods and apparatus for intracranial electrical stimulation to treat or otherwise effectuate a change in neural-functions of a patient. Several embodiments of methods in accordance with the invention are directed toward enhancing or otherwise inducing a lasting change in neural activity to effectuate a particular neural-function. Such lasting change in neural activity is defined as “neuroplasticity.” The methods in accordance with the invention can be used to treat brain damage (e.g., stroke, trauma, etc.), brain disease (e.g., Alzheimer's, Pick's, Parkinson's, etc.), and/or brain disorders (e.g., epilepsy, depression, etc.). The methods in accordance with the invention can also be used to enhance neural-function of normal, healthy brains (e.g., learning, memory, etc.), or to control sensory functions (e.g., pain).
    Type: Application
    Filed: February 15, 2006
    Publication date: September 7, 2006
    Applicant: Northstar Neuroscience, Inc.
    Inventors: Andrew Firlik, Jeffrey Balzer, Bradford Gliner, Alan Levy, Carlton Morgan
  • Publication number: 20060195155
    Abstract: The following disclosure describes several methods and apparatus for intracranial electrical stimulation to treat or otherwise effectuate a change in neural-functions of a patient. Several embodiments of methods in accordance with the invention are directed toward enhancing or otherwise inducing a lasting change in neural activity to effectuate a particular neural-function. Such lasting change in neural activity is defined as “neuroplasticity.” The methods in accordance with the invention can be used to treat brain damage (e.g., stroke, trauma, etc.), brain disease (e.g., Alzheimer's, Pick's, Parkinson's, etc.), and/or brain disorders (e.g., epilepsy, depression, etc.). The methods in accordance with the invention can also be used to enhance neural-function of normal, healthy brains (e.g., learning, memory, etc.), or to control sensory functions (e.g., pain).
    Type: Application
    Filed: March 27, 2006
    Publication date: August 31, 2006
    Applicant: Northstar Neuroscience, Inc.
    Inventors: Andrew Firlik, Jeffrey Balzer, Bradford Gliner, Alan Levy, Carlton Morgan
  • Publication number: 20060142806
    Abstract: A method and article for storing an automatic external defibrillator for use without a prescription are described. The hermetically sealed electrode pads of the OTC AED are electrically coupled to the OTC AED base unit where they are constantly accessible to self-test circuitry inside the base unit for periodic, automatic self-test. In one embodiment the self-test is designed to determine whether the conductive gel of the electrode pads has dried out. In another embodiment self-test circuitry also tests the battery while the OTC AED is being stored prior to use.
    Type: Application
    Filed: March 14, 2005
    Publication date: June 29, 2006
    Inventors: Wendy Katzman, Thomas Lyster, Thomas Solosko, Carlton Morgan, Kim Hansen, Daniel Powers, Hans Griesser, Eric Jonsen, David Snyder
  • Patent number: 6553257
    Abstract: A method for reducing delay between termination of cardiopulmonary resuscitation and administration of a defibrillating shock. An electrocardiogram signal of the patient is monitored during administration of cardiopulmonary resuscitation to a patient. The electrocardiogram signal is analyzed to determine whether a shockable rhythm exists. It is indicated that a shockable rhythm exists and/or that a defibrillating shock will be administered. Cardiopulmonary resuscitation is stopped. The defibrillating shock is administered within 10 seconds of the cessation of cardiopulmonary resuscitation.
    Type: Grant
    Filed: March 13, 2001
    Date of Patent: April 22, 2003
    Assignee: Koninklijke Philips Electronics N.V.
    Inventors: David Snyder, Carlton Morgan
  • Publication number: 20030043136
    Abstract: The application relates to an information transfer system, comprising a receiver (3) and a transmitter (1) for transferring an information signal to the receiver (3) via a transfer medium (2). The information signal comprises main data and sub data. The sub data comprises coded text lines having a plurality of character codes. The receiver is provided with a character display unit (10) for displaying characters corresponding with the character codes in the coded text lines. The number of character display positions is less than the number of character codes in the coded text line. The receiver is provided with display control means (9) for controlling the display of characters corresponding to the character codes included in the coded text line in dependence on serial control codes included in the coded text line.
    Type: Application
    Filed: October 17, 2002
    Publication date: March 6, 2003
    Applicant: Koninklijke Philips Electronics N.V.
    Inventors: David Snyder, Carlton Morgan
  • Publication number: 20020133197
    Abstract: A method for reducing delay between termination of cardiopulmonary resuscitation and administration of a defibrillating shock. An electrocardiogram signal of the patient is monitored during administration of cardiopulmonary resuscitation to a patient. The electrocardiogram signal is analyzed to determine whether a shockable rhythm exists. It is indicated that a shockable rhythm exists and/or that a defibrillating shock will be administered. Cardiopulmonary resuscitation is stopped. The defibrillating shock is administered within 10 seconds of the cessation of cardiopulmonary resuscitation.
    Type: Application
    Filed: March 13, 2001
    Publication date: September 19, 2002
    Inventors: David Snyder, Carlton Morgan
  • Patent number: 5483165
    Abstract: This invention is a battery monitor and battery capacity indicator that uses a sense cell in addition to the main battery to determine main battery remaining capacity and depletion condition. A parameter of the sense cell is related to the main battery capacity so that the main battery will have a minimum capacity remaining when the sense cell parameter reaches a particular value or crosses a particular threshold. In a preferred embodiment, the sense cell is a battery which is identical and of the same manufacturing lot as the battery cell or cells in the main battery pack. A current is drawn from the sense cell that is larger than the current being drawn from the main battery. When the sense cell is fully depleted, the main battery will have a remaining capacity whose magnitude depends on the relationship between the main battery current and the sense cell current.
    Type: Grant
    Filed: January 14, 1994
    Date of Patent: January 9, 1996
    Assignee: Heartstream, Inc.
    Inventors: David B. Cameron, Daniel Powers, Thomas Lyster, Carlton Morgan